26.12 USD
+0.66
2.59%
At close Apr 2, 4:00 PM EDT
After hours
25.93
-0.19
0.73%
1 day
2.59%
5 days
-3.51%
1 month
1.40%
3 months
3.69%
6 months
16.76%
Year to date
3.69%
1 year
14.16%
5 years
36.33%
10 years
4.15%
0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 6 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

30% more call options, than puts

Call options by funds: $10.9M | Put options by funds: $8.4M

10% more capital invested

Capital invested by funds: $1.25B [Q3] → $1.38B (+$124M) [Q4]

8% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 63

8% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 26

1% less funds holding

Funds holding: 190 [Q3] → 188 (-2) [Q4]

1.2% less ownership

Funds ownership: 95.46% [Q3] → 94.25% (-1.2%) [Q4]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$29
11%
upside
Avg. target
$32
24%
upside
High target
$35
34%
upside

6 analyst ratings

positive
100%
neutral
0%
negative
0%
Canaccord Genuity
Richard Close
41% 1-year accuracy
11 / 27 met price target
34%upside
$35
Buy
Maintained
13 Mar 2025
Needham
Ryan MacDonald
36% 1-year accuracy
30 / 84 met price target
11%upside
$29
Buy
Reiterated
13 Mar 2025
Piper Sandler
Jessica Tassan
38% 1-year accuracy
9 / 24 met price target
26%upside
$33
Overweight
Reiterated
29 Jan 2025
Citigroup
Daniel Grosslight
39% 1-year accuracy
9 / 23 met price target
34%upside
$35
Buy
Maintained
10 Jan 2025
Keybanc
Scott Schoenhaus
17% 1-year accuracy
2 / 12 met price target
15%upside
$30
Overweight
Maintained
8 Jan 2025

Financial journalist opinion

Based on 5 articles about PHR published over the past 30 days

Positive
Seeking Alpha
2 weeks ago
Phreesia Maintains Its Momentum
Phreesia remains resilient, maintaining guidance and showing strong financial performance, with Q4 revenue growth of 15% year-over-year and improved cash flow. Despite a slight deceleration in customer growth, Phreesia's revenue per healthcare services client increased, driven by network solutions, and the company expects 13.6% revenue growth in fiscal 2026. Future growth drivers include patient education initiatives and Post-Script Engagement, while competition is seen as beneficial, enhancing market awareness and adoption of healthcare solutions.
Phreesia Maintains Its Momentum
Neutral
Business Wire
2 weeks ago
Phreesia Named to G2's List of 2025 Best Healthcare Software Products
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia has been named to G2's 2025 Best Software Awards in the Best Healthcare Software Products category.
Phreesia Named to G2's List of 2025 Best Healthcare Software Products
Neutral
Seeking Alpha
2 weeks ago
Phreesia, Inc. (PHR) Q4 2025 Earnings Call Transcript
Phreesia, Inc. (NYSE:PHR ) Q4 2025 Earnings Conference Call March 12, 2025 5:00 PM ET Company Participants Balaji Gandhi - CFO Chaim Indig - Co-Founder, CEO & Director Conference Call Participants Anne Samuel - JPMorgan Jessica Tassan - Piper Sandler Jailendra Singh - Triust Securities Ryan Daniels - William Blair Richard Close - Canaccord Genuity Ryan MacDonald - Needham & Company Jeff Garro - Stephens Daniel Grosslight - Citi Group Scott Schoenhaus - KeyBanc Capital Markets Operator Good evening, ladies and gentlemen, and welcome to Phreesia's Fourth Quarter Fiscal 2025 Earnings Conference Call. [Operator Instructions] First, I would like to introduce Balaji Gandhi, Phreesia's Chief Financial Officer.
Phreesia, Inc. (PHR) Q4 2025 Earnings Call Transcript
Negative
Zacks Investment Research
2 weeks ago
Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates
Phreesia (PHR) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.56 per share a year ago.
Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates
Neutral
Business Wire
3 weeks ago
Phreesia Announces Fourth Quarter Fiscal 2025 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2025. "We are pleased with our solid finish to fiscal 2025 and I am excited about the new products we have introduced over the past several quarters that improve medication adherence and the overall patient and provider experience," said CEO and Co-Founder Chaim Indig. Please visit the Phr.
Phreesia Announces Fourth Quarter Fiscal 2025 Results
Positive
Zacks Investment Research
1 month ago
Phreesia (PHR) Moves 5.6% Higher: Will This Strength Last?
Phreesia (PHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Phreesia (PHR) Moves 5.6% Higher: Will This Strength Last?
Neutral
Business Wire
1 month ago
Phreesia's Sally Thayer Selected as a Top Woman Leader in Software
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that Sally Thayer, VP of Product Management, is a winner for The Software Report's 2024 list of Top 50 Women Leaders in Software.
Phreesia's Sally Thayer Selected as a Top Woman Leader in Software
Neutral
Business Wire
1 month ago
Phreesia Sets Release Date for Fiscal Fourth Quarter and Fiscal Year 2025 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal fourth quarter and fiscal year 2025 financial results after the close of market trading on Wednesday, March 12.
Phreesia Sets Release Date for Fiscal Fourth Quarter and Fiscal Year 2025 Results
Positive
Zacks Investment Research
2 months ago
Phreesia, Inc. (PHR) Soars to 52-Week High, Time to Cash Out?
Phreesia (PHR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Phreesia, Inc. (PHR) Soars to 52-Week High, Time to Cash Out?
Neutral
Zacks Investment Research
2 months ago
Zacks Industry Outlook Enovis, Omnicell and Phreesia
Enovis, Omnicell and Phreesia have been highlighted in this Industry Outlook article.
Zacks Industry Outlook Enovis, Omnicell and Phreesia
Charts implemented using Lightweight Charts™